Answers are grounded in this paper and cite their sources.
Background and aims Intravaginal insertion of smokeless tobacco ( taba ) is an emerging, little‐researched method of tobacco use practiced in several countries in sub‐Saharan Africa. This study aimed to characterise patterns of intravaginal taba use and the motivations, perceived benefits, adverse effects and dependence associated with this practice among women in The Gambia and examined whether this practice represents an unrecognised nicotine exposure pathway. Design Qualitative study using in‐depth semi‐structured interviews with current and former users of taba recruited through the Medical Research Council Unit The Gambia Pregnancy Care Integrating Translational Science Everywhere (PRECISE) and Mothers Health Foundation databases and supplemented by snowball sampling. Data were analysed thematically. Setting Urban and rural communities across four health regions of The Gambia. Participants Forty‐two women aged 18–49 years who were current ( n = 31) or former ( n = 11) users of taba , recruited through community networks and health research programmes. Measurements Interviews explored initiation, patterns of use, composition and preparation of taba , perceived benefits and harms, risk perceptions and indicators of dependence. We translated, transcribed and analysed the data using a deductive–inductive thematic approach. Results Women commonly initiated taba use for perceived therapeutic purposes, particularly treatment of vaginal infections, pain and reproductive health concerns. Social networks strongly influenced initiation, and early adverse physiological reactions, such as burning, vomiting and dizziness, were frequently normalised as evidence of effectiveness. Its continued use was reinforced by perceived sexual, health and emotional benefits, including vaginal tightening, enhanced pleasure and relief from loneliness or unmet sexual needs. Participants indicated that products often contain potentially toxic additives (caustic soda, ashes, battery acid). Many reported symptoms consistent with nicotine toxicity and described progression to habitual use, characterised by cravings, withdrawal symptoms and difficulty quitting despite recognised harms, including suspected cancer and reproductive complications. Secrecy and stigma surrounding use were common. Summary In The Gambia, intravaginal smokeless tobacco ( taba ) use appears to be initiated for perceived therapeutic and sexual health benefits, but users report experiences consistent with nicotine dependence and exposure to harmful additives in taba products, highlighting a previously unrecognised form of tobacco exposure among women.
No takes yet. Share an insight, caveat, or question.
Cham et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: